Cargando…

The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro

Detalles Bibliográficos
Autores principales:	Li, Xia, Höhl, Rainer, Sörgel, Fritz, Fuhr, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301348/ https://www.ncbi.nlm.nih.gov/pubmed/32556540 http://dx.doi.org/10.1007/s00228-020-02928-7

Ejemplares similares

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given
por: Malviya, Amit
Publicado: (2020)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Linschoten, Marijke, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Lammers, A.J.J., et al.
Publicado: (2021)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings
por: Mvumbi, Dieudonné M.
Publicado: (2020)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020)

Reply to the Letter to Editor by Lacout and colleagues: Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
por: Prasad, Manya, et al.
Publicado: (2021)

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine
por: Verheijen, S., et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine during pregnancy: What do we know?
por: Lacroix, Isabelle, et al.
Publicado: (2020)

Fixed Drug Eruption to Hydroxychloroquine
por: Swarnkar, Bhavya, et al.
Publicado: (2021)

Response to: Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis
por: Boglione, Lucio, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine for cancer therapy
por: Manic, Gwenola, et al.
Publicado: (2014)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
por: Stevens, David M., et al.
Publicado: (2020)

Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis – Authors reply
por: Kumar, Jogender, et al.
Publicado: (2021)

Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out
por: De Franceschi, Lucia, et al.
Publicado: (2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
por: Wang, Manli, et al.
Publicado: (2020)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020)

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Hydroxychloroquine/chloroquine and azithromycin in COVID-19 patients: prospective study of electrical parameters
por: Ammor, Othmane, et al.
Publicado: (2021)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Impact of COVID-19 on Advanced Cancer Patients’ Pain Care: Warning About Chloroquine and Hydroxychloroquine
por: Aminnejad, Reza, et al.
Publicado: (2021)

Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
por: Farrell, Donald F
Publicado: (2012)

Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19
por: D’Acquarica, Ilaria, et al.
Publicado: (2020)

Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review
por: Carvalho, Alzira Alves de Siqueira
Publicado: (2020)

Management of Chloroquine and Hydroxychloroquine Poisoning: Do Not Miss the Time of Tracheal Intubation and Mechanical Ventilation
por: Megarbane, Bruno, et al.
Publicado: (2021)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
por: Gies, Vincent, et al.
Publicado: (2020)

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
por: Lebin, Jacob A., et al.
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ghjrl90j6prirolbr2g15slrrn